The Australian Islet Study Group (AISG) Meeting is the premier meeting for researchers interested in all aspects of islet and beta cell function; including secretion pathway mechanisms, islet structure and function, morphology, in vitro and in vivo models, omics and big data considerations. We invite you to attend this exciting annual meeting discussing islet biology as it relates to clinical situations including diabetes and challenges in islet transplantation. The AISG Meeting 2024 will take place on Wednesday, 15th & Thursday, 16th May 2024 at The Westmead Institute for Medical Research in Westmead, NSW.

Click here for abstract submission details.
Click here for the preliminary program.
Click here to register for the event.

Full registration: A$190.00 (GST included)
Student registration: A$90.00 (GST included)

Abstract Submission

Abstract submission deadline extended to Monday, 6 May 2024.

Abstracts should be emailed to ads@diabetessociety.com.au. Please format and organise the abstract as specified below, and include all outlined information. Please provide the following:

Author Information
State all authors, with presenting author’s name underlined. Please indicate if the presenting author is a young investigator (PhD student or Postdoctoral fellow less than 5 years post PhD graduation).

State full first and last names and affiliation details for each author.

Abstract Format
•   A4 (portrait)
•   500 words maximum
•   Abstract title in bold

Abstract Layout
Organise the abstract with the following sections: Background, Objectives, Methods, Results, Conclusions

Presentation Format at the 2024 AISG Meeting
Below the abstract, please state the name, email address and phone number of the submitting author. All submitted abstracts will be presented as posters.

You will receive a confirmation email after submission. The Committee will review all submitted abstracts. Notification regarding abstract acceptance and scheduling will be sent to the submitting author.

Speakers

Keynote Speaker Professor Lori Sussel Lori Sussel is the Research Director of the Barbara Davis Diabetes Center (BDC) and Director of the NIDDK-funded University of Colorado Diabetes Research Center. She received her graduate degree from Columbia University Medical School and pursued a postdoctoral fellowship at the University of California, San Francisco. Her research program involves two major areas of study. One aspect of her research is to understand the biology underlying pancreatic islet cell development and function. These studies have contributed to the ability to grow human islet cells in a dish for cell replacement therapy in type 1 diabetes (T1D). The second aspect of her research is to understand why the immune system targets the insulin producing beta cells within the pancreas with hopes that this knowledge will help prevent disease initiation or protect the beta cells after disease onset. As BDC Research Director, Professor Sussel has also established an internationally recognised interdisciplinary research division focusing on all aspects of T1D research and discovery.

Program

Click to view the preliminary program.